IMCL

ImClone reports overall survival results from Phase III lung cancer trial - 09/01 - 10:59 AM ET

Imclone Systems Picks Up Volume, Challenges Support - 08/29 - 12:04 PM ET

ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced - 08/29 - 12:00 PM ET

ImClone Systems initiates enrollment in Phase II prostate cancer study - 08/27 - 06:22 AM ET

Randomized Phase 2 Study of IMC-A12 and IMC-1121B for Advanced Prostate Cancer Commences Patient Enrollment - 08/26 - 07:00 AM ET

ImClone initiates Phase III metastatic breast cancer trial - 08/15 - 11:26 AM ET

Global Phase 3 Study of IMC-1121B in Metastatic Breast Cancer Commences - 08/13 - 07:00 AM ET

IMCL: To Present At IBC Life Sciences DDT 2008 Conference @ 09:00 ET [delayed] - 08/04 - 07:23 AM ET

Imclone Systems Closes At 4-Year High - 07/31 - 04:35 PM ET

IMCLONE SYSTEMS UP 41% TO $65.34 IN PREMARKET; BRISTOL-MYERS PROPOSES TO BUY - 07/31 - 09:03 AM ET

Imclone Systems Soars In Pre-Market On Buyout Offer - 07/31 - 08:01 AM ET

mClone Systems Sets Date to Host Second Quarter 2008 Financial Results Conference Call - 07/24 - 04:26 PM ET

IMCL: Q2 Earnings Call @ 11:00 ET Today [delayed] - 07/24 - 08:24 AM ET

Imclone Systems Closes At Two Month High - 07/21 - 04:21 PM ET

ImClone Systems Schedules July 24 Earnings Call - 07/21 - 12:10 AM ET

ImClone Systems to Host Second Quarter 2008 Financial Results Conference Call - 07/18 - 04:30 PM ET

ImClone Systems (IMCL) NewsBite - ImClone Price Target Lifted - 07/17 - 02:09 AM ET

ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer - 07/16 - 08:34 AM ET

ImClone to initiate patient enrollment in Phase II sarcoma study - 07/08 - 09:56 AM ET

ImClone Systems Inc (IMCL) Corporate Event Announcement Notice - 07/03 - 08:58 PM ET

Page 1 of 11     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index